Sport, Childhood and Chagas

Happy to announce the agreement between Mundo Sano Foundation and World Health Oganization

8 November 2017 | Geneva −− The World Health Organization (WHO) and the Mundo Sano Foundation are working to make an essential antiparasitic medicine for treatment of Chagas disease widely accessible to children. Treatment with benznidazole in the early stages of infection can cure the […]

U.S. FDA Approves Chemo Group’s Benznidazole to Treat Children with Chagas Disease

On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research’s New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas disease.

Benznidazole is an essential medicine for Chagas disease, a dangerous parasitic disease that […]

III Edition of #RetoChagas in Spain

Cycling 750km from Madrid to Lisboa to give visibility to the Chagas

Today August 28 begins in Madrid, for the third year in a row, an activity promoted by Chemo Group called Reto Chagas, which consists of a bike route of 750 kilometers, crossing the peninsula […]

Mundo Sano attends the 160th annual meeting of the Executive Committee of PAHO

The Executive Committee of the Pan American Health Organization (PAHO) began its 160th annual meeting on Monday, June 26 at its headquarters in Washington DC.
The delegations of PAHO member countries, such as Argentina, Brazil, Chile, Colombia, the United States, Antigua and Barbuda, Guatemala, Panama and […]

Did you know…?
It is estimated that in Spain there are 48,000 to 86,000 people infected with Chagas disease.
Every year, 500,000 people are hospitalized with dengue virus.
26 million school-age children are exposed to various intestinal worms or soil-transmitted helminths.
In 2014, more than 15,000 suspected cases of Chikungunya were reported in the Caribbean.
Approximately 500 million people in the Americas are at risk of infection with dengue.
The four dengue serotypes (DENV-1, DENV-2, DENV-3 and DEN-V 4) circulate throughout the Americas, in some countries simultaneously.
Worldwide, more than 12 million people are infected with leishmaniasis, and 350 million people are at risk.
It is estimated that 75% of all cases of cutaneous leishmaniasis are concentrated in 10 countries, four of which are in the Americas: Brazil, Colombia, Peru and Nicaragua.
Chagas is an endemic disease in 21 countries of the Americas, and affects 6 to 8 million people.
Every year, 28,000 new cases of Chagas disease are reported in the Americas. And 8,000 newborns are infected during pregnancy.
Approximately 65 million people are exposed to Chagas disease in the Americas.
In Argentina, at least one and a half million inhabitants are infected, and more than 300,000 people suffer heart disorders associated with Chagas disease.